REPORTING

REPORT YOUR ONGOING HEALTH

The form below allows you to report your health status to your primary healthcare provider, and/or your local health bureau. Filling out the form will produce an email that can be immediately sent to your healthcare practitioner and/or to your local health authority.

INDICAID® OTC COVID-19 TEST REPORTING FORM

      
Result Report
ENTER THE CAPTCHA CODE FROM BELOW
      
             
             
       Reload
      
I agree to the Privacy Policy and Terms of Service.
   
             

Our company accepts no liability for the content of the email created by this form, or for the consequences of any actions taken on the basis of the information provided, unless that information is subsequently confirmed in writing. If you are not the intended recipient you are notified that disclosing, copying, distributing or taking any action in reliance on the contents of this information is strictly prohibited.

INFORMATION

Results

POSITIVE: If a Control (C) line and the Test (T) line are visible, the test is positive. Any faint visible red test (T) with the control line (C) should be read as positive.

NEGATIVE: If the Control (C) line is visible, but the test line is not visible, the test is negative.

INVALID: No red-colored line next to the “C” means the test is invalid. Re-test with a new swab and new test device. If there is no red line next to the “C”, the result is invalid regardless of whether there is a red-colored line next to the “T”.

FDA DISCLAIMER

In the USA, the INDICAID® COVID-19 RAPID ANTIGEN TEST has not been FDA cleared or approved, but has been authorized by FDA under an Emergency Use Authorization. This product has been authorized only for the detection of proteins from SARS-Cov-2, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C § 360bbb-3(b)(1), unless the declaration is terminated, or authorization is revoked sooner.